Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVK
2576
Advent Convertible and Income Fund
AVK
$561M
| $22.3M | ﹤0.01% |
1,913,834
-2,188,706
| -53% | -$25M |
|
2577
Bausch Health
BHC
$2.32B
| $22.2M | ﹤0.01% |
2,093,845
-2,289,829
| -52% | -$20M |
|
|
NLOP
2578
Net Lease Office Properties
NLOP
$177M
| $22.2M | ﹤0.01% |
933,078
-758,670
| -45% | -$17.9M |
|
2579
Flywire
FLYW
$2.25B
| $22.2M | ﹤0.01% |
894,434
-220,454
| -20% | -$5.15M |
|
2580
PROG Holdings
PRG
$1.83B
| $22.2M | ﹤0.01% |
644,286
-1,301,938
| -67% | -$40.9M |
|
2581
ProShares Short QQQ
PSQ
$721M
| $22.2M | ﹤0.01% |
506,404
-1,583,293
| -76% | -$72.1M |
|
2582
Supernus Pharmaceuticals
SUPN
$2.68B
| $22.2M | ﹤0.01% |
650,226
-796,484
| -55% | -$23.7M |
|
2583
iShares S&P India Nifty 50 Index Fund
INDY
$569M
| $22.2M | ﹤0.01% |
439,580
-309,892
| -41% | -$15.5M |
|
2584
Banc of California
BANC
$3.07B
| $22.2M | ﹤0.01% |
1,457,649
-2,463,045
| -63% | -$34.3M |
|
|
VRN
2585
DELISTED
Veren
VRN
| $22.1M | ﹤0.01% |
2,699,418
-3,701,114
| -58% | -$25.9M |
|
2586
Astec Industries
ASTE
$1.05B
| $22.1M | ﹤0.01% |
505,650
-664,376
| -57% | -$24.8M |
|
2587
PDF Solutions
PDFS
$2.12B
| $22.1M | ﹤0.01% |
655,676
-1,197,450
| -65% | -$39.3M |
|
2588
Palomar
PLMR
$3.54B
| $22.1M | ﹤0.01% |
263,082
-324,080
| -55% | -$22.2M |
|
2589
Kymera Therapeutics
KYMR
$8.64B
| $22M | ﹤0.01% |
547,140
-335,416
| -38% | -$12M |
|
|
EAD
2590
Allspring Income Opportunities Fund
EAD
$378M
| $22M | ﹤0.01% |
3,308,064
-2,872,894
| -46% | -$19.1M |
|
2591
Wabash National
WNC
$508M
| $21.9M | ﹤0.01% |
731,853
-788,527
| -52% | -$20.8M |
|
2592
Jack in the Box
JACK
$344M
| $21.9M | ﹤0.01% |
319,664
-187,650
| -37% | -$14.1M |
|
2593
Ambev
ABEV
$47B
| $21.9M | ﹤0.01% |
8,813,143
-13,929,375
| -61% | -$36.3M |
|
2594
Asana
ASAN
$2.01B
| $21.9M | ﹤0.01% |
1,410,688
-1,276,996
| -48% | -$22.9M |
|
2595
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.57B
| $21.9M | ﹤0.01% |
959,636
-1,675,058
| -64% | -$37.1M |
|
|
ETV
2596
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.75B
| $21.8M | ﹤0.01% |
1,688,979
-1,725,019
| -51% | -$22M |
|
2597
Stock Yards Bancorp
SYBT
$2.65B
| $21.8M | ﹤0.01% |
445,963
-430,711
| -49% | -$20.4M |
|
2598
First Commonwealth Financial
FCF
$2.2B
| $21.8M | ﹤0.01% |
1,565,550
-1,479,922
| -49% | -$20.4M |
|
2599
Greif
GEF
$5.07B
| $21.8M | ﹤0.01% |
315,227
-215,693
| -41% | -$13.8M |
|
|
AXNX
2600
DELISTED
Axonics, Inc. Common Stock
AXNX
| $21.8M | ﹤0.01% |
315,589
-258,361
| -45% | -$17.4M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.